/ Blog/ Were You a Pregnant Mother Taking Zofran During Your First Trimester?
WKW is currently reviewing Zofran injury cases for mothers who took Zofran during the first trimester of pregnancy, and have a child with a confirmed birth injury, such as heart defects of cleft lip or palete. Contact one of our Indianapolis birth injury attorneys for your free case evaluation.
Zofran (Ondansetron) is a prescription medication used to treat nausea and vomiting associated with cancer chemotherapy and radiation. It is also prescribed as a means to prevent nausea and/or vomiting after surgery. Zofran is manufactured by U.K.-based pharmaceutical company GlaxoSmithKline, and was first approved by the U.S. Food and Drug Administration (FDA) in January 1999.
Despite the fact that Zofran and its generic ondansetron were only approved for the treatment of nausea and vomiting after chemotherapy, radiation, or to patients after surgery, physicians were/are using Zofran as an off-label treatment option for morning sickness (nausea and vomiting of pregnancy, or NVP) in pregnant women.
GlaxoSmithKline soon acknowledged the potential for a brand new market, and, without FDA approval, began marketing Zofran to physicians and expectant mothers as a way to treat NVP. Roughly 1 million pregnant women are prescribed Zofran every year.
The FDA has classified Zofran as a “Pregnancy Category B” drug, meaning that it has not been the subject of any well-controlled studies to determine the effects Zofran may have during pregnancy. However, the FDA has approved “Pregnancy Category A” drug called Diclegis, to safely treat morning sickness in pregnant women. All “Pregnancy Category A” drugs have been adequately tested and deemed safe for use during pregnancy.
Zofran is in a class of medications called serotonin 5-HT3 receptor antagonists. Zofran works by blocking the secretion of serotonin–a natural neurotransmitter–in certain parts of the brain that may cause nausea and vomiting.
In March 2013, the FDA confirmed in an Adverse Events Report that the use of Zofran may be linked to a condition called serotonin syndrome. Serotonin syndrome is caused by a heavy increase of serotonin, and can result in excessive nerve activity in the brain. Symptoms of serotonin syndrome can develop within hours of taking Zofran. The most common being:
A Zofran birth defect study published in Reproductive Toxicology consisted of an analysis 1.5 million births. Roughly 1,349 of those babies were born between 1998 and 2012, and whose mothers took Zofran during the early stages of their pregnancies. After careful examination, it was concluded that Zofran should not be prescribed as an off-label treatment option for morning sickness, as the results showed that taking Zofran during the first trimester/early pregnancy increased the risk for heart defects in babies.
While these findings were powerful, researchers still urged for further studies to sufficiently determine an increased risk for Zofran heart defects, and to determine if any more cardiac defects were possible.
Boston University’s Slone Epidemiological Center and Harvard University examined the use of ondansentron in the first trimester of pregnancy and found that babies born to mothers who took the medication for morning sickness were more than 2.37 times more likely to have a cleft palate.
Victims across the country are filing drug injury lawsuits against Zofran’s manufacturer for allegedly:
If you were prescribed Zofran during your first trimester of pregnancy, and have a child with a heart defect or cleft palate, you may be entitled to compensation for:
While there are no guarantees that a court will rule in your favor, the costs associated with multiple surgeries, lifesaving procedures, and long-term therapies will undeniably add up over time. Not to mention the fact that at no point in time should you have ever been misguided through illegal advertising on behalf of GlaxoSmithKline. It’s your turn to fight back and hold GlaxoSmithKline accountable.
If your child has suffered birth defects as a result of taking Zofran during your first trimester, contact an Indianapolis drug injury attorney at Wilson Kehoe Winingham for your free case evaluation.
November 24, 2016
Our Indianapolis personal injury attorneys at Wilson Kehoe Winingham are now reviewing cases for victims who suffered from excessive bleeding from taking Xarelto or other blood thinners. Contact us for a …Read More
November 22, 2016
If you’re a woman experiencing severe complications from transvaginal mesh, you may be eligible for compensation. Contact an experienced transvaginal mesh lawyer at WKW for your free consultation. What is …Read More
Fill out the form below to receive a free and confidential initial consultation.